Visionary Healthcare Investors
BioStar Capital is making a difference in patients' lives with uncompromising fund performance.
Business Acumen Meets
Clinical Expertise
The BioStar team represents a unique collaboration between experienced investment professionals and clinicians with global reputations as medical thought leaders.
Innovations with an Impact
For over 17 years, BioStar Capital has been at the forefront of transformational medical technology through partnerships with innovative companies.
Portfolio News
September 29, 2021
TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
September 7, 2021
TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
BioStar News
May 25, 2021
Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence
January 15, 2021
DeviceTalks Weekly features Mark Toland, BioStar Entrepreneur-in-Residence: Digging into the Digital Medtech & Surgical Worlds